Plain-English translation of NCT06880016 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different ways to give surfactant — a natural substance that helps premature babies breathe — to infants born before 32 weeks of pregnancy who have respiratory distress syndrome. One method involves briefly placing a breathing tube, delivering the medication, and then removing the tube. The other method delivers the medication through a thin catheter while the baby stays on their regular breathing support. Doctors will use ultrasound imaging of the lungs to see how well each approach works.
Respiratory distress syndrome is a serious breathing problem in premature babies caused by immature lungs that don't produce enough surfactant. While surfactant therapy is the proven treatment, doctors want to understand which delivery method works best and causes the least stress to vulnerable newborns.
You likely qualify if…
You likely don't qualify if…
Your baby will be randomly assigned to receive surfactant using one of two methods: either a brief intubation approach or a thin catheter approach that keeps your baby on their regular breathing support throughout. Doctors will perform ultrasound imaging of your baby's lungs at different time points to track recovery and compare how well each method reduces breathing problems. The study is conducted in the neonatal intensive care unit where your baby is already receiving care.
AI-generated summary from trial data · Aug 29, 2026 · Not medical advice
Turkey (Türkiye)